2013
DOI: 10.3354/dao02600
|View full text |Cite
|
Sign up to set email alerts
|

Sequence-optimized and targeted double-stranded RNA as a therapeutic antiviral treatment against infectious myonecrosis virus in Litopenaeus vannamei

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 25 publications
0
7
0
Order By: Relevance
“…It is thus not possible to predict, without undertaking longer-term challenge trials, to what level and over what time period shrimp would remain protected against developing acute IMNV infection and associated disease. Nonetheless, the promising results reported here and elsewhere (Tirasophon et al 2007, Loy et al 2012, 2013 clearly justify follow-up studies to examine whether RNAi approaches can be applied in breeding programs, hatcheries, or farms to effectively suppress IMNV infection over the life of L. vannamei, thus minimizing risks of IMN production losses occurring during culture.…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…It is thus not possible to predict, without undertaking longer-term challenge trials, to what level and over what time period shrimp would remain protected against developing acute IMNV infection and associated disease. Nonetheless, the promising results reported here and elsewhere (Tirasophon et al 2007, Loy et al 2012, 2013 clearly justify follow-up studies to examine whether RNAi approaches can be applied in breeding programs, hatcheries, or farms to effectively suppress IMNV infection over the life of L. vannamei, thus minimizing risks of IMN production losses occurring during culture.…”
Section: Discussionmentioning
confidence: 72%
“…The RNAi mechanism exists in shrimp, where it can be mobilized as a component of the antiviral defense response. Synthetic dsRNAs targeted to various viral and host gene sequences have thus been investigated for their ability to activate prophylactic RNAi responses against viruses including the Taura syndrome virus (TSV, Robalino et al 2004), white spot syndrome virus (WSSV, Robalino et al 2005), yellow head virus (YHV, Yodmuang et al 2006, Tirasophon et al 2007, and IMNV (Loy et al 2013). To activate the RNAi mechanism in shrimp effectively, long dsRNA molecules have been delivered by injection.…”
Section: Introductionmentioning
confidence: 99%
“…The injection dose depends on the size and the RNAi sensitivity of the target species and tissues and usually ranges from about 5 to 1000 ng per injection. Haemolymph injection (Yodmuang et al 2006;Ongvarrasopone et al 2011) and intramuscular injection (Kim et al 2007;Loy et al 2013;Hou et al 2014) are used to deliver dsRNA into bigger shrimp species (Table 2).…”
Section: Molecular Mechanismmentioning
confidence: 99%
“…As the major challenge regarding the use of RNAi as antiviral treatment in mammals has been the delivery method 7 , 8 , this has been more promising in invertebrates due to the systemic nature of RNAi in many of these species. Trials in farmed shrimps have shown that muscular injection of dsRNA can be used therapeutically against yellow head virus and infectious myonecrosis virus, at least to decrease the viral load and increase survival rate of infected animals 9 11 . In insects such as the honeybee, oral treatment with dsRNA simultaneously with virus inoculation has been shown to induce resistance to the israeli acute paralysis virus (IAPV) 12 , and even large scale application of dsRNA against this virus has been attempted 13 .…”
Section: Introductionmentioning
confidence: 99%